Page last updated: 2024-10-27

furosemide and Protein-Losing Enteropathies

furosemide has been researched along with Protein-Losing Enteropathies in 1 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research Excerpts

ExcerptRelevanceReference
" We report successful diuretics treatment with spironolactone and furosemide at standard dose, of refractory PLE in a patient with Noonan syndrome and repaired congenital heart disease."3.81Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome. ( Iemura, M; Kudo, Y; Matsuishi, T; Mizuochi, T; Seki, Y; Suda, K; Tanikawa, K; Yanagi, T; Yoshimoto, H, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mizuochi, T1
Suda, K1
Seki, Y1
Yanagi, T1
Yoshimoto, H1
Kudo, Y1
Iemura, M1
Tanikawa, K1
Matsuishi, T1

Other Studies

1 other study available for furosemide and Protein-Losing Enteropathies

ArticleYear
Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome.
    Pediatrics international : official journal of the Japan Pediatric Society, 2015, Volume: 57, Issue:2

    Topics: Child; Diuretics; Female; Fontan Procedure; Furosemide; Heart Defects, Congenital; Humans; Noonan Sy

2015